Annual Accounts Payable
$635.00 K
+$205.00 K+47.67%
December 31, 2023
Summary
- As of March 10, 2025, CTNM annual accounts payable is $635.00 thousand, with the most recent change of +$205.00 thousand (+47.67%) on December 31, 2023.
- During the last 3 years, CTNM annual accounts payable has fallen by -$25.00 thousand (-3.79%).
- CTNM annual accounts payable is now -3.79% below its all-time high of $660.00 thousand, reached on December 1, 2021.
Performance
CTNM Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.40 M
+$663.00 K+90.33%
September 30, 2024
Summary
- As of March 10, 2025, CTNM quarterly accounts payable is $1.40 million, with the most recent change of +$663.00 thousand (+90.33%) on September 30, 2024.
- Over the past year, CTNM quarterly accounts payable has stayed the same.
- CTNM quarterly accounts payable is now at all-time high.
Performance
CTNM Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
CTNM Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +47.7% | 0.0% |
| 3 y3 years | -3.8% | +224.9% |
| 5 y5 years | -3.8% | +224.9% |
CTNM Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -3.8% | +47.7% | at high | +224.9% |
| 5 y | 5-year | -3.8% | +47.7% | at high | +224.9% |
| alltime | all time | -3.8% | +47.7% | at high | +224.9% |
Contineum Therapeutics Class A Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.40 M(+90.3%) |
| Jun 2024 | - | $734.00 K(+28.8%) |
| Mar 2024 | - | $570.00 K(-10.2%) |
| Dec 2023 | $635.00 K | $635.00 K(-39.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $1.05 M(+145.1%) |
| Dec 2022 | $430.00 K(-34.8%) | - |
| Dec 2022 | - | $430.00 K |
| Dec 2021 | $660.00 K | - |
FAQ
- What is Contineum Therapeutics Class A annual accounts payable?
- What is the all time high annual accounts payable for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A annual accounts payable year-on-year change?
- What is Contineum Therapeutics Class A quarterly accounts payable?
- What is the all time high quarterly accounts payable for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A quarterly accounts payable year-on-year change?
What is Contineum Therapeutics Class A annual accounts payable?
The current annual accounts payable of CTNM is $635.00 K
What is the all time high annual accounts payable for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high annual accounts payable is $660.00 K
What is Contineum Therapeutics Class A annual accounts payable year-on-year change?
Over the past year, CTNM annual accounts payable has changed by +$205.00 K (+47.67%)
What is Contineum Therapeutics Class A quarterly accounts payable?
The current quarterly accounts payable of CTNM is $1.40 M
What is the all time high quarterly accounts payable for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high quarterly accounts payable is $1.40 M
What is Contineum Therapeutics Class A quarterly accounts payable year-on-year change?
Over the past year, CTNM quarterly accounts payable has changed by $0.00 (0.00%)